Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04685499
Title Phase 2 Study of OBP-301 (Telomelysin) in Combination With Pembrolizumab and SBRT in Patients With HNSCC With Inoperable, Recurrent or Progressive Disease
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Weill Medical College of Cornell University
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Weill Cornell Medicine New York New York 10065 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field